Sep 16, 2021 Repligen has entered into an agreement to acquire Avitide in a $150,000,000 deal.

Repligen based at Waltham, Massachusetts, United States.
“Repligen: Inspiring Advances in Bioprocessing. Learn more about our innovative products, technologies and bioprocessing applications”

Acquirer’s Website: http://www.repligen.com

Avitide based at Lebanon, New Hampshire, United States. “Avitide is dedicated to advancing our partners’ clinical pipelines and commercial manufacturing processes with a rapid, exclusive, and enabling affinity purification platform technology.”

Acquiree’s Website: http://www.avitide.com